Skip to main content
Premium Trial:

Request an Annual Quote

Checking Out Heart Health in the Heartland

If you've had trouble explaining the pros and cons of direct-to-consumer genetic testing to your family, this will help: the Indianapolis Star has a story on the budding field, featuring interviews with people who have signed up for these services as well as with scientists. The story quotes Indiana University geneticist Gail Vance as saying, "People need to understand it's an evolving science. ... The test could be underestimating or overestimating risk based on the studies available now. That's one of the biggest risks."

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.